Cargando…
Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
OBJECTIVE: Chronic exposure to calcineurin inhibitors and corticosteroids poses renal transplant recipients (RTR) at high risk for development of new-onset diabetes after transplantation (NODAT). Pancreatic β-cell dysfunction may be crucial to the pathophysiology of NODAT and specific markers for β-...
Autores principales: | Zelle, Dorien M., Corpeleijn, Eva, Deinum, Jolijn, Stolk, Ronald P., Gans, Rijk O.B., Navis, Gerjan, Bakker, Stephan J.L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687295/ https://www.ncbi.nlm.nih.gov/pubmed/23378624 http://dx.doi.org/10.2337/dc12-1894 |
Ejemplares similares
-
Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Klaassen, Gerald, et al.
Publicado: (2017) -
Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: Design of the Active Care after Transplantation (ACT) randomized controlled trial
por: Klaassen, Gerald, et al.
Publicado: (2017) -
Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation
por: Zelle, Dorien M., et al.
Publicado: (2016) -
Plasma Malondialdehyde and Risk of New-Onset Diabetes after Transplantation in Renal Transplant Recipients: A Prospective Cohort Study
por: Yepes-Calderón, Manuela, et al.
Publicado: (2019) -
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: Abbasi, Ali, et al.
Publicado: (2014)